Britain is grappling with widespread shortages of aspirin, a vital medication for preventing strokes and heart attacks in vulnerable patients. The government has responded by adding aspirin to its export ban list, aiming to safeguard supplies for UK patients, with manufacturing delays cited as a primary cause.
Both the National Pharmacy Association (NPA), representing approximately 6,000 pharmacies, and the Independent Pharmacies Association, with over 5,000 members, report significant difficulties in sourcing the drug.
